Revvity, Inc. (RVTY) Dividend History

Revvity, Inc. (RVTY) is a global provider of laboratory testing, diagnostic products, and healthcare solutions. The company focuses on advancing scientific research and medical diagnostics through innovative technologies and comprehensive testing services, supporting healthcare providers and research institutions worldwide.

940 Winter Street, Waltham, MA, 02451
Phone: 781-663-5791
Website: https://www.revvity.com

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
August 08, 2025	$0.07	07/18/2025	07/18/2025
May 09, 2025	$0.07	04/17/2025	04/18/2025
February 07, 2025	$0.07	01/17/2025	01/17/2025
November 08, 2024	$0.07	10/18/2024	10/18/2024
August 09, 2024	$0.07	07/19/2024	07/19/2024
May 10, 2024	$0.07	04/18/2024	04/19/2024
February 09, 2024	$0.07	01/18/2024	01/19/2024
November 10, 2023	$0.07	10/19/2023	10/20/2023
August 11, 2023	$0.07	07/20/2023	07/21/2023
May 12, 2023	$0.07	04/20/2023	04/21/2023
February 10, 2023	$0.07	01/19/2023	01/20/2023
November 11, 2022	$0.07	10/20/2022	10/21/2022
August 12, 2022	$0.07	07/21/2022	07/22/2022
May 13, 2022	$0.07	04/21/2022	04/22/2022
February 11, 2022	$0.07	01/20/2022	01/21/2022
November 12, 2021	$0.07	10/21/2021	10/22/2021
August 06, 2021	$0.07	07/15/2021	07/16/2021
May 07, 2021	$0.07	04/15/2021	04/16/2021
February 12, 2021	$0.07	01/21/2021	01/22/2021
November 06, 2020	$0.07	10/15/2020	10/16/2020
August 07, 2020	$0.07	07/16/2020	07/17/2020
May 08, 2020	$0.07	04/16/2020	04/17/2020
February 07, 2020	$0.07	01/16/2020	01/17/2020
November 08, 2019	$0.07	10/17/2019	10/18/2019
August 09, 2019	$0.07	07/18/2019	07/19/2019
May 10, 2019	$0.07	04/17/2019	04/19/2019
February 08, 2019	$0.07	01/17/2019	01/18/2019
November 09, 2018	$0.07	10/18/2018	10/19/2018
August 10, 2018	$0.07	07/19/2018	07/20/2018
May 10, 2018	$0.07	04/12/2018	04/13/2018
February 09, 2018	$0.07	01/18/2018	01/19/2018
November 10, 2017	$0.07	10/19/2017	10/20/2017
August 10, 2017	$0.07	07/19/2017	07/21/2017
May 10, 2017	$0.07	04/11/2017	04/14/2017
February 10, 2017	$0.07	01/18/2017	01/20/2017
November 10, 2016	$0.07	10/12/2016	10/14/2016
August 10, 2016	$0.07	07/13/2016	07/15/2016
May 10, 2016	$0.07	04/13/2016	04/15/2016
February 10, 2016	$0.07	01/13/2016	01/15/2016
November 10, 2015	$0.07	10/14/2015	10/16/2015
August 10, 2015	$0.07	07/15/2015	07/17/2015
May 11, 2015	$0.07	04/15/2015	04/17/2015
February 06, 2015	$0.07	01/14/2015	01/16/2015
November 07, 2014	$0.07	10/15/2014	10/17/2014
August 08, 2014	$0.07	07/16/2014	07/18/2014
May 09, 2014	$0.07	04/15/2014	04/18/2014
February 07, 2014	$0.07	01/15/2014	01/17/2014
November 08, 2013	$0.07	10/16/2013	10/18/2013
August 09, 2013	$0.07	07/17/2013	07/19/2013
May 10, 2013	$0.07	04/17/2013	04/19/2013
February 08, 2013	$0.07	01/16/2013	01/18/2013
November 09, 2012	$0.07	10/17/2012	10/19/2012
August 10, 2012	$0.07	07/18/2012	07/20/2012
May 11, 2012	$0.07	04/18/2012	04/20/2012
February 10, 2012	$0.07	01/18/2012	01/20/2012
November 11, 2011	$0.07	10/19/2011	10/21/2011
August 12, 2011	$0.07	07/20/2011	07/22/2011
May 13, 2011	$0.07	04/19/2011	04/22/2011
February 11, 2011	$0.07	01/19/2011	01/21/2011
November 12, 2010	$0.07	10/20/2010	10/22/2010
August 13, 2010	$0.07	07/21/2010	07/23/2010
May 07, 2010	$0.07	04/14/2010	04/16/2010
February 12, 2010	$0.07	01/20/2010	01/22/2010
November 13, 2009	$0.07	10/21/2009	10/23/2009
August 07, 2009	$0.07	07/15/2009	07/17/2009
May 08, 2009	$0.07	04/15/2009	04/17/2009
February 06, 2009	$0.07	01/14/2009	01/16/2009
November 07, 2008	$0.07	10/15/2008	10/17/2008
August 08, 2008	$0.07	07/16/2008	07/18/2008
May 09, 2008	$0.07	04/16/2008	04/18/2008
February 08, 2008	$0.07	01/16/2008	01/18/2008
November 09, 2007	$0.07	10/17/2007	10/19/2007
August 10, 2007	$0.07	07/18/2007	07/20/2007
May 11, 2007	$0.07	04/18/2007	04/20/2007
February 09, 2007	$0.07	01/17/2007	01/19/2007
November 10, 2006	$0.07	10/18/2006	10/20/2006
August 11, 2006	$0.07	07/19/2006	07/21/2006
May 12, 2006	$0.07	04/19/2006	04/21/2006
February 10, 2006	$0.07	01/18/2006	01/20/2006
November 11, 2005	$0.07	10/19/2005	10/21/2005
August 12, 2005	$0.07	07/20/2005	07/22/2005
May 13, 2005	$0.07	04/20/2005	04/22/2005
February 11, 2005	$0.07	01/19/2005	01/21/2005
November 12, 2004	$0.07	10/20/2004	10/22/2004
August 13, 2004	$0.07	07/21/2004	07/23/2004
May 14, 2004	$0.07	04/21/2004	04/23/2004
February 05, 2004	$0.07	01/14/2004	01/16/2004

Dividends Summary

Revvity, Inc. has issued 87 dividend payments over the past 21 years
The most recent dividend was paid 29 days ago, on May 9, 2025
The first recorded dividend was paid on February 5, 2004
The highest dividend payout was $0.07 per share
The average dividend over this 21 year span is $0.07 per share

Company News

Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight

The metastatic colorectal cancer clinical trial pipeline is accelerating, with over 150 pharmaceutical companies rigorously developing drugs for market entry. This indicates a positive sentiment for the industry as it aims to address the rising incidence of the disease.

GlobeNewswire Inc.

Featured Companies: LH PKI QDEL TMO
High Content Screening and Imaging Market Set for 8.4% CAGR Through 2029

The high content screening/imaging (HCS/I) market is projected to reach $5.1 billion by 2029, growing at a CAGR of 8.4%. Increasing R&D budgets and technological advances in HCS/I, such as AI integration, automation, and 3D cell models, are driving the market growth.

GlobeNewswire Inc.

Featured Companies: A BDX BIO BIO.B BRKR CRL DHR GLW TMO
Neurogenomics Market Forecast and Trends Analysis to 2031: Healthcare Investments and Early Detection Drive Robust Uptake of Neurogenomics Solutions

The neurogenomics market is projected to reach $4.68 billion by 2031, driven by declining sequencing costs, increasing prevalence of neurological disorders, and advancements in sequencing technologies. Key players include Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, and others.

GlobeNewswire Inc.

Featured Companies: A DHR ILMN PACB QGEN TMO
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology

The global infectious disease diagnostics market is projected to reach $43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period. The market is driven by advancements in diagnostic technologies, rising cases of infectious diseases, and increased R&D funding.

Benzinga

Featured Companies: ABT BDX BIO BIO.B CODX DHR OSUR QDEL QGEN TMO
CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs

The global CRISPR-based gene editing market is expected to reach $9.14 billion by 2030, driven by advancements in CRISPR technology, increasing prevalence of genetic disorders, and growing investments in biotechnology research.

GlobeNewswire Inc.

Featured Companies: BIO BIO.B DHR MRK TECH

Dividend data last updated 06/06/2025 20:24:42 UTC